Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease.
Zhu, L., George, S., Schmidt, M.F., Al-Gharabli, S.I., Rademann, J., Hilgenfeld, R.(2011) Antiviral Res 92: 204-212
- PubMed: 21854807 
- DOI: 10.1016/j.antiviral.2011.08.001
- Primary Citation of Related Structures:  
3SN8, 3SNA, 3SNB, 3SNC, 3SND, 3SNE - PubMed Abstract: 
SARS coronavirus main protease (SARS-CoV M(pro)) is essential for the replication of the virus and regarded as a major antiviral drug target. The enzyme is a cysteine protease, with a catalytic dyad (Cys-145/His-41) in the active site. Aldehyde inhibitors can bind reversibly to the active-site sulfhydryl of SARS-CoV M(pro) ...